Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways (GAP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01161056|
Recruitment Status : Completed
First Posted : July 13, 2010
Last Update Posted : September 10, 2015
|Condition or disease|
|Immune System Diseases|
The primary purpose of this research is to develop a better understanding of how the immune system works. By studying immune function in many people, we will be able to determine the range of normal variation.
The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).
Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.
|Study Type :||Observational|
|Actual Enrollment :||5000 participants|
|Official Title:||Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways|
|Study Start Date :||May 2009|
|Actual Primary Completion Date :||April 2015|
|Actual Study Completion Date :||April 2015|
|Healthy Control Group|
- Number of healthy participants enrolled [ Time Frame: 5 years ]This is a registry to enroll healthy individuals who are interested in being contacted about research studies they can participate in as a healthy control
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01161056
|United States, New York|
|The Feinstein Institute for Medical Research|
|Manhasset, New York, United States, 11030|
|Principal Investigator:||Peter Gregersen, MD||The Feinstein Institute for Medical Research|